Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
Citation
Colhoun , H M , Livingstone , S J , Looker , H C , Morris , A D , Wild , S H , Lindsay , R S , Reed , C , Donnan , P T , Guthrie , B , Leese , G P , McKnight , J , Pearson , D W M , Pearson , E , Petrie , J R , Philip , S , Sattar , N , Sullivan , F M , McKeigue , P & Scottish Diabetes Research Network (SDRN) Epidemiology group 2012 , ' Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs ' , Diabetologia , vol. 55 , no. 11 , pp. 2929-2937 . https://doi.org/10.1007/s00125-012-2668-0